Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Pregabalin and Trigger Point Injection With Ropivacaine in the Treatment of Myofascial Pain Syndrome.

NCT07866443 is registered in ClinicalTrials.gov with National and Kapodistrian University of Athens as lead sponsor.

NCT NCT07866443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07866443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Pregabalin and Trigger Point Injection With Ropivacaine in the Treatment of Myofascial Pain Syndrome.
Lead sponsor
National and Kapodistrian University of Athens
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2025
Completion date
December 20, 2025
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myofascial pain syndrome - neck